New PHIL Research on the Future of Pharma DTP: 3 in 4 Leaders Report Direct-to-Patient a Major Strategic Priority Today, Growing 20% in “Mission Critical” Significance in 2027

A survey of 74 U.S. life sciences leaders finds that the mission-critical urgency of direct-to-patient initiatives is rising. The report provides no further figures or company-specific financial implications.